Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005594-36Phase 4Completed
Phase 4, randomised, double-blind trial of polidocanol + urea in chronic kidney disease-associated pruritus (CKD-aP) (2 arms), sponsored by Portsmouth Hospitals University NHS Trust. Primary endpoint: Reduction in itch intensity. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005594-36.